CLINICAL ROLE -
Survey: 2 in 5 Americans Doubt Vaccine Safety
The AOA recommends that prescribers not argue with their patients who may be against vaccinations, but instead, provide information and resources on the benefits and remain as a resource for any potential questions.
Read More
Turmeric May Be the Answer to Osteosarcoma Treatment
As young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery, researchers wanted to develop gentler treatment options.
New Treatment for Refractory Multiple Myeloma Granted FDA Approval
Selinexor (Xpovio, Karyopharm) tablets in combination with the corticosteroid dexamethasone was approved under the agency's accelerated approval program.
FDA Grants Accelerated Approval to Selinexor for Heavily Pretreated Multiple Myeloma
Selinexor (Xpovio, Karyopharm) received approval in combination with dexamethasone for heavily-pretreated patients with relapsed or refractory multiple myeloma.
New Research Offers Insight on Potential Therapeutic Targets for Rheumatoid Arthritis, Lupus
Three new studies looked at the mechanisms involved in tissue damage related to rheumatoid arthritis and lupus.
The FOXA1 Gene in Prostate Cancer: Fast, Furious, and Loud
FOXA1 has been previously known to be mutated in prostate cancer; however, its biological functions were not understood well.
Turning to Technology for Managing Drug Shortages
One company, LogicStream Health, creates software that integrates with a hospital EHR system for multiple platform services.
Trending News Today: Study Examines Treatment Patterns in Patients with Psoriatic Arthritis
Top news of the day from across the health care landscape.
Targeting HIV Transmission Rates
Health care professionals, including pharmacists and nurse practitioners, play a critical role in attaining goals for reducing HIV transmission.
New Study Shows Drug Shortages Have a Large Impact on Hospitals
Drug shortages can adversely affect patient care in the community and hospital settings.
Aptevo Launches New Ixinity Assay for Patients with Hemophilia B
Aptevo Therapeutics announced the launch of its new vial size for its coagulation factor IX recombinant (Ixinity) treatment for hemophilia B in the US market.
Adherence to Prophylactic Treatment Improves Physical Activity in Hemophilia A
A recent study showed that adherence to prophylaxis for severe hemophilia A can improve a patient’s physical performance.
Trending News Today: No Significant Difference Found in HIV Risk Based on Contraceptive Used
Water Safety Tips for the Silent Killer Among Children: Drowning
Water safety is important, especially with summertime here, but it is crucial for parents to remain vigilant all year round.
Product News: New Label Color for Medication Requiring Special Handling
Medi-Dose® has created bright yellow Lid-Label® Covers for use with our Circular and Oval Medi-Cup® Blisters.
Pharmacy Student with Flair for Science to Compete for Title of Miss America
Camille Schrier, a PharmD student at the VCU School of Pharmacy, used a fun science experiment to showcase her talent during the Miss Virginia pageant.
More than 5 Million Patients with Cancer History in the US Have Chronic Pain
Specific types of cancer—such as bone, kidney, throat, and uterine—also had a higher incidence of chronic and severe pain that restricted daily activity.
Monday Pharmaceutical Mystery: July 1
What is causing excessive bruising in a patient?
Long-Lasting Inhibition of Radiographic Progression Shown with Secukinumab for Psoriatic Arthritis
Treatment with secukinumab (Cosentyx, Novartis) inhibited radiographic progression in most patients with psoriatic arthritis over 2 years in a phase 3 trial.
Trending News Today: Louisiana, Asegua Partner for 5-Year Hepatitis C Treatment Plan
CDC: 2018-2019 Flu Season the Longest in a Decade
The 21-week 2018-2019 influenza season was the longest in 10 years.
Managing Travel Vaccinations at Community Pharmacies
Bruce Kneeland, community pharmacy consultant, discusses how community pharmacists can counsel and manage travel vaccinations at their pharmacies, in an interview with Pharmacy Times.
Watch
New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria
Retrophin's enteric-coated formulation allows administration with or without food.
FDA Approves New Formulation of Tiopronin for Cystinuria
Officials with the FDA have approved a new enteric-coated formulation of tiopronin (Thiola EC, Retrophin) 100 mg and 300 mg tablets, for the treatment of cystinuria.
Ryan White HIV/AIDS Program Funding Awarded to Counties in Need
This funding is part of an effort to provide technical assistance to enhance efforts to end the HIV epidemic.
Doorstep Delivery: CourMed Brings Medications to Patients
Technology solutions such as CourMed will allow better pharmacist-patient communication, adherence, and overall improved patient outcomes.
Pharmacists, Techs Discuss Pharmacy Retail Layoffs
Pharmacists are taking to social media in response to layoffs at Walmart pharmacies across the country.
FDA Approves Biosimilar to Bevacizumab for Treatment of 5 Cancers
Pfizer’s bevacizumab-bvzr (Zirabev) demonstrated clinical equivalence and no clinically meaningful differences compared with the reference product.
FDA OKs Pfizer's Biosimilar to Bevacizumab
Pfizer’s bevacizumab-bvzr (Zirabev) demonstrated clinical equivalence and no clinically meaningful differences compared with the reference product.
CDC Analysis Underscores Need for More HIV Testing
Fewer than 40% of people have ever had a HIV test, and less than 30% of people in the United States most at risk of acquiring HIV were tested in the past year.